| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5901917 | Journal of Diabetes and its Complications | 2016 | 37 Pages |
Abstract
This large pooled analysis suggests that linagliptin is effective and well tolerated in people with T2DM and liver disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Nobuya Inagaki, Wayne H.-H. Sheu, David R. Owens, Susanne Crowe, Amit Bhandari, Yan Gong, Sanjay Patel,